Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-295090 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
199,865
Total Value
$9,191,973.72
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 61,378 | $5.33 | $327,144.74 | 321,992 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Sale | 1,500 | $110.54 | $165,809.55 | 320,492 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Sale | 1,700 | $111.57 | $189,664.07 | 318,792 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Sale | 1,100 | $112.79 | $124,066.91 | 317,692 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Sale | 4,110 | $114.19 | $469,310.62 | 313,582 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Sale | 51,375 | $114.77 | $5,896,288.20 | 262,207 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Sale | 7,971 | $115.82 | $923,178.10 | 254,236 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Sale | 6,153 | $116.99 | $719,862.24 | 248,083 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 30, 2026 | Sale | 3,200 | $117.70 | $376,649.28 | 244,883 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 61,378 | $0.00 | $0.00 | 0 | Direct | โ | View Details |